Central venous catheters used for hemodialysis continue to be associated with high rates of bloodstream infections. In this article, Michiel Betjes reviews the evidence showing that such ...

The effectiveness of various solutions instilled into the central venous catheter lumens after each hemodialysis session (catheter locking solutions) to decrease the risk of catheter malfunction an ...

The hemodialysis catheters market value is projected to reach USD 1.3 billion by 2028, according to a new research report by Global Market Insights Inc.

LOS ANGELES, July 13, 2022 (GLOBE NEWSWIRE) -- The Global Hemodialysis Catheters Market size accounted for USD 787 Million in 2021 and is estimated to reach the market value of USD 1,214 Million ...

Brian Wang, Nextbigfuture, interviewed Joseph Todicso, CEO of Cormedix. DefenCath™ is Cormedix formulation of taurolidine and heparin that will greatly reduce dialysis infections for those using ...

Multifaceted quality improvement interventions may prevent hemodialysis catheter-related bloodstream infections outside the ICU, however, more research is needed, according to published data ...

Hemodialysis blood-flow rates increased after either alteplase 1 mg/mL per port or urokinase 5000 units per port was used to clear presumed catheter thrombosis.

Global Hemodialysis Catheters Market to Reach $1 Billion by 2030 In the changed post COVID-19 business landscape, the global market for Hemodialysis Catheters estimated at US$747.6 Million in the year ...

Hemodialysis catheters were excluded in this study. Catheter patency was restored in 86.2% of catheters with a 0.5-mg alteplase dose.